Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-01-31 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于董事、监事和高级管理人员持股情况变动报告的公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding changes in shareholdings of the company's directors, supervisors, and senior management following a non-public issuance of shares. It details the shareholding numbers and percentages before and after the issuance, emphasizing that the shareholding quantities did not change but the proportions did due to increased total shares. The document is not a full financial report, audit, or earnings release, but a specific disclosure about insider shareholding changes. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or holdings by company directors and executives.
2018-01-31 Chinese
2017年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2017 annual performance forecast (业绩预告) from 三诺生物传感股份有限公司, covering the period from January 1, 2017 to December 31, 2017. It provides estimated net profit figures and explanations for performance changes but explicitly states that the data is unaudited and preliminary. It also mentions that detailed financial data will be disclosed in the 2017 Annual Report. The document is short (923 characters) and serves as a performance forecast announcement rather than a full financial report. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only, rather than a full Annual Report (10-K).
2018-01-30 Chinese
关于媒体报道的澄清公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 三诺生物传感股份有限公司 clarifying media reports about a potential acquisition bid involving Johnson & Johnson's diabetes care business. It details the company's current status regarding the transaction, the uncertainty involved, and the regulatory and internal approval processes required. The document also mentions the temporary suspension and resumption of trading of the company's stock. There are no financial statements, detailed financial data, or management analysis present. The document serves as a clarification and risk disclosure related to a potential M&A activity but does not itself constitute an M&A filing or a detailed transaction document. It is an official announcement addressing market rumors and investor information. Given the content and length (1452 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-01-23 Chinese
关于核实重大事项暨停牌的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (三诺生物传感股份有限公司) regarding the verification of a major matter and the suspension of trading of its stock. It references regulatory rules from the Shenzhen Stock Exchange and states the stock will be suspended pending verification of the matter. The document is only 594 characters long and does not contain any financial data, detailed reports, or results. It is clearly an announcement about a trading halt and information verification, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2018-01-19 Chinese
北京国枫律师事务所关于公司发行股份购买资产并募集配套资金之标的资产过户情况的法律意见书
Regulatory Filings
2018-01-15 Chinese
中信证券股份有限公司关于公司发行股份购买资产并募集配套资金之资产交割的独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor's Verification Opinion" regarding the asset delivery for a transaction involving issuance of shares to purchase assets and raise supporting funds by SanNuo Bio-sensing Co., Ltd. It details the transaction scheme, approval procedures, asset delivery status, and subsequent matters. The document is a professional verification and opinion report by an independent financial advisor (CITIC Securities) on the completion of asset delivery and compliance with regulatory approvals for a major asset restructuring transaction. It does not contain full financial statements or quarterly/yearly financial results, nor is it a transcript, announcement of voting results, or a simple notice. It is a standalone audit-related verification report focused on the asset purchase and capital raising transaction, consistent with the definition of an Audit Report / Information (AR). The document length (6782 characters) and detailed content support it being a full report rather than a brief announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information).
2018-01-15 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.